From the publishers of JADPRO
Chronic Lymphocytic Leukemia
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Case Studies
Richter Transformation to Hodgkin Lymphoma
“Double-Refractory” CLL: Progressive Disease after Therapy With Both a BTK Inhibitor and a BCL2 Inhibitor
Measurable Residual Disease With Time-limited Venetoclax-based Regimens: Clinical Standards, Nuances
Venetoclax Alone and In Combination: Overcoming Ibrutinib Resistance
Management of Atrial Fibrillation in Patients With CLL on BTK Inhibitors
The Importance of Shared Decision-Making in the Frontline Setting
Advertisement
Case Studies
“Double-Refractory” CLL: Progressive Disease after Therapy With Both a BTK Inhibitor and a BCL2 Inhibitor
Management of Atrial Fibrillation in Patients With CLL on BTK Inhibitors
The Importance of Shared Decision-Making in the Frontline Setting
Advertisement
Quizzes
Test your knowledge on management of atrial fibrillation in patients with CLL on BTK inhibitors
Test your knowledge about decision making in the CLL frontline setting
Test your knowledge about venetoclax